Nordic Bioproducts Group Ltd site in Lappeenranta, Finland RECEIVES EXCiPACT GMP CERTIFICATION AS PHARMACEUTICAL EXCIPIENT SUPPLIER

EXCiPACT is pleased to announce that the Nordic Bioproducts Group Ltd in Lappeenranta, Finland has recently been awarded an EXCiPACT GMP and GDP Certificate from ACT, one of EXCIPACT’s internationally recognised Certification Bodies.

The Certificate demonstrates that this site manufactures and distributes Microcrystaline Cellulose (MCC-AaltoCellTM) for the Pharmaceutical Industry according to the 2021 EXCiPACT Certification Standard for Pharmaceutical Excipient Suppliers.